Literature DB >> 28943496

Clinical implications of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion: role of antegrade and retrograde crossing techniques.

Aurel Toma1, Barbara E Stähli, Cathérine Gebhard, Michael Gick, Jan Minners, Kambis Mashayekhi, Alexandre Avran, Miroslaw Ferenc, Heinz Joachim Buettner, Franz-Josef Neumann.   

Abstract

AIMS: Periprocedural myocardial injury (PMI) is frequently observed after percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). We aimed to investigate the prognostic impact of PMI with the antegrade as compared to the retrograde crossing technique. METHODS AND
RESULTS: A total of 1,909 patients undergoing CTO PCI were stratified according to the presence/absence of PMI (elevation of cardiac troponin T [cTnT] >5x99th percentile of normal), and divided according to tertiles of the difference between peak and baseline cTnT within 24 hours (∆cTnT). The primary endpoint was all-cause mortality at a median follow-up of 3.1 (interquartile range 3.0-4.4) years. PMI occurred in 19.4% and 25.4% after antegrade (n=1,447) and retrograde (n=462) procedures (p<0.001). PMI was significantly associated with mortality after antegrade (adjusted HR 1.39, 95% CI: 1.02-1.88, p=0.04), but not retrograde CTO PCI (adjusted HR 0.93, 95% CI: 0.53-1.63, p=0.80, pint=0.02). With the antegrade, but not with the retrograde approach, mortality also increased with tertiles of ∆cTnT (T1: 11.0%, T2: 18.6%, T3: 21.6%, log-rank p<0.001).
CONCLUSIONS: Periprocedural myocardial injury was significantly associated with all-cause mortality following antegrade, but not retrograde CTO PCI. Hence, the higher risk of PMI following retrograde procedures did not translate into worse survival.

Entities:  

Mesh:

Year:  2018        PMID: 28943496     DOI: 10.4244/EIJ-D-17-00338

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.

Authors:  Yun-Jie Yin; Yan-Chun Chen; Liang Xu; Xiang-Hai Zhao
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-26

2.  Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Authors:  Mei-Jun Liu; Chao-Feng Chen; Xiao-Fei Gao; Xiao-Hua Liu; Yi-Zhou Xu
Journal:  Coron Artery Dis       Date:  2020-05       Impact factor: 1.717

3.  Postprocedural Troponin Elevation and Mortality After Transcatheter Aortic Valve Implantation.

Authors:  Matthias Schindler; Florin Stöckli; Rico Brütsch; Philipp Jakob; Erik Holy; Jonathan Michel; Robert Manka; Paul Vogt; Christian Templin; Markus Kasel; Frank Ruschitzka; Barbara E Stähli
Journal:  J Am Heart Assoc       Date:  2021-10-29       Impact factor: 5.501

4.  Clinical Characteristics and Risk Factors of Periprocedural Myocardial Injury in Patients with Elective PCI in a TCM Hospital.

Authors:  Xiang Li; He-Yi Zhang; Ju-Ju Shang; Hong-Xu Liu; Qi Zhou; Xiao-Lei Lai
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-24       Impact factor: 2.629

Review 5.  The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).

Authors:  Johannes Mair; Allan Jaffe; Bertil Lindahl; Nicholas Mills; Martin Möckel; Louise Cullen; Evangelos Giannitsis; Ola Hammarsten; Kurt Huber; Konstantin Krychtiuk; Christian Mueller; Kristian Thygesen
Journal:  Biomarkers       Date:  2022-05-26       Impact factor: 2.663

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.